As discussed below, the most common RET fusions, in papillary thyroid carcinoma (PTC) and in lung adenocarcinoma (LADC) are CCDC6-RET and NCOA4-RET (primarily in PTC) and KIF5B-RET (primarily in LADC). This evidence concerns the gene RET and thyroid gland papillary carcinoma.